Evidence map›Paper›PMID 42282851›Full record

ArticleBiochemistry and biophysics reports2026

Comprehensive characterization of the human neural stem cell line HNSC.100 as a versatile model for neurobiological research.

Estera Jeruzalska, Carolin Ketteler, Elisa Stützenberger, Sandra Burczyk, Larissa Möller, Dierk Niessing

Abstract read
In one paragraph

Article in Biochemistry and biophysics reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Estera JeruzalskaInstitute of Pharmaceutical Biotechnology, Ulm University, James-Franck-Ring N27, Ulm, 89081, Germany.
Carolin KettelerMolecular Targets and Therapeutics Center, Institute of Structural Biology, Helmholtz Zentrum München, German Research Center for Environmental Health, Ingolstädter Landstr. 1, Neuherberg, 85764, Germany.
Elisa StützenbergerInstitute of Pharmaceutical Biotechnology, Ulm University, James-Franck-Ring N27, Ulm, 89081, Germany.
Sandra BurczykInstitute of Pharmaceutical Biotechnology, Ulm University, James-Franck-Ring N27, Ulm, 89081, Germany.
Larissa MöllerInstitute of Pharmaceutical Biotechnology, Ulm University, James-Franck-Ring N27, Ulm, 89081, Germany.
Dierk NiessingInstitute of Pharmaceutical Biotechnology, Ulm University, James-Franck-Ring N27, Ulm, 89081, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Studying neural-related questions is inherently challenging due to the limited number of suitable cell models. Here, we characterize a previously reported immortalized human neural stem cell line, HNSC.100, serving as a robust model for a wide range of neurobiological research questions. The cell line expresses key neural stem cell markers, including SOX2, vimentin, nestin, and allows for efficient genetic manipulation. Furthermore, HNSC.100 cells can be differentiated into neurons, astrocytes, and oligodendrocytes, thereby covering a wide spectrum of major neural cell types. We adapted corresponding differentiation protocols and established a comprehensive panel of molecular markers to validate successful differentiation, enabling precise characterization of the resulting cell population. In addition, we provide a complete dataset of RNA expression levels for all detectable genes in HNSC.100 cells. Based on this dataset, we assembled a list of expressed genes implicated in neural disorders that can be studied with this cell line. Together, we present a detailed characterization of the HNSC.100 cell line and provide new tools and reference data to facilitate its use. This resource enables researchers to evaluate the line's suitability for specific applications and to rapidly integrate HNSC.100 cells into their experimental workflows.

Indexed as

AstrocyteshNS1Human neural stem cellsImmortalized cell lineNeurodegenerationNeurodevelopmentNeuronsOligodendrocytes

Identifiers

PMID42282851
PMCPMC13251743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.